APA (7th ed.) Citation

RB, D., TB, K., LF, D., J, R., W, S., EM, P., . . . ND, H. (2024). Author Correction: CIS is a potent checkpoint in NK cell-mediated tumor immunity. Nature immunology, 25(2), 371. https://doi.org/10.1038/s41590-023-01714-8

Chicago Style (17th ed.) Citation

RB, Delconte, et al. "Author Correction: CIS Is a Potent Checkpoint in NK Cell-mediated Tumor Immunity." Nature Immunology 25, no. 2 (2024): 371. https://doi.org/10.1038/s41590-023-01714-8.

MLA (9th ed.) Citation

RB, Delconte, et al. "Author Correction: CIS Is a Potent Checkpoint in NK Cell-mediated Tumor Immunity." Nature Immunology, vol. 25, no. 2, 2024, p. 371, https://doi.org/10.1038/s41590-023-01714-8.